Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |